This paper attempts to consider an aspect of the ethical issues involved with xenotransplantation, using the concept of “technologization of human nature” as a clue. First, we present an overview of the challenges with xenotransplantation, and examine some representative ethical issues among them. Second, we examine concerns about “unnaturalness” that accompany xenotransplantation. Using the concept of “technologization of human nature,” introduced by Habermas, we discuss the sense of value that is considered to be behind this concern. Particularly from an ethical standpoint, three issues are frequently mentioned: human dignity, the boundaries and integrity of the species, and the use of animals. From a technological viewpoint, these three issues are not likely to cause such serious ethical problems. However, if a vague hesitation over xenotransplantation remains, there may be a lingering concern about its unnaturalness. Although unnaturalness does not directly lead to an ethical conclusion, it is premature to eliminate the concern about unnaturalness as mere conjecture so that society may accept xenotransplantation. In discussing this concern about unnaturalness, we focus on Habermas's concept of “technologization of human nature.” Habermas's discussion guides us to an assumption of fears behind the concern about unnaturalness: that the body may be instrumentalized, that the sense may be lost that the body is vulnerable and incapable of manipulating as intended, or that the sense of awe for life may be impaired. Apparently, the idea of awe for life has religious connotations. However, Sandel used the term “giftedness of life” and demonstrated that awe for life is comprehensible without depending on any particular religion. Discussions of Habermas and Sandel could infer that the concern about unnaturalness may not be duly eliminated so simply. However, they do not deny the intervention for disease treatment. Xenotransplantation may deserve further research if the expected benefit is large. For that very reason, the issues arising from targeting its clinical application should be on the table now.
View full abstract